Development of a New Score Based on Image Defined Risk Factors to Standardize Surgical Risk in Neuroblastoma Resection - A SIOPEN Collaborative Study

In brief

This SIOPEN collaborative study develops a novel scoring system to standardize surgical risk assessment in neuroblastoma resection by stratifying Image Defined Risk Factors (IDRFs) based on their actual impact on resectability. The research addresses the clinical challenge that IDRFs persist in 70% of cases post-chemotherapy but vary significantly in their surgical implications.

• Image Defined Risk Factors (IDRFs) persist in 70% of neuroblastoma cases despite neoadjuvant chemotherapy.
• Not all IDRFs carry equal surgical significance; presence of an IDRF does not automatically mean unresectability.
• A new scoring system stratifies individual IDRFs by their actual impact on surgical risk in neuroblastoma resection.
• SIOPEN collaborative data enables standardization of surgical risk assessment beyond binary IDRF presence/absence.
• Refined IDRF scoring may improve surgical planning and patient selection for resection after chemotherapy.

Written by the GCMD Library team from the article.